Zealand Pharma appoints head of R&D as CEO

On Wednesday, Zealand Pharma has announced that Adam Steensberg, the company’s head of research and development, will become its new chief executive.
Photo: Zealand Pharma
Photo: Zealand Pharma
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

As a part of a larger restructuring of the company, Zealand Pharma has announced on Wednesday that its executive vice president of research and development and chief medical officer, Adam Steensberg, will become its new chief executive office, according to a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading